360 High-Risk Vulnerability Immunization Tool V2.0 vs AhnLab EDR: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

AhnLab EDR: EDR solution with behavioral analytics and MITRE ATT&CK mapping. built by AhnLab. Core capabilities include Behavioral analytics with MITRE ATT&CK mapping, Graphical visualization of attack chains and threat paths, User-defined static and dynamic behavior rule sets..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. AhnLab EDR differentiates with Behavioral analytics with MITRE ATT&CK mapping, Graphical visualization of attack chains and threat paths, User-defined static and dynamic behavior rule sets.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). AhnLab EDR is developed by AhnLab. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.

360 High-Risk Vulnerability Immunization Tool V2.0 and AhnLab EDR serve similar Endpoint Protection Platform use cases. Review the feature comparison above to determine which fits your requirements.